XML 20 R29.htm IDEA: XBRL DOCUMENT v2.4.0.6
Fair Value of Financial Instruments (Tables)
9 Months Ended
Sep. 30, 2012
Fair Value of Financial Instruments [Abstract]  
Fair Value of Financial Instruments in the Balance Sheet
Following is a summary of the Company's financial instruments which have been valued at fair value in the Company's Consolidated Balance Sheets at September 30, 2012 and December 31, 2011:

 
Fair Value Based on Quoted Prices in Active Markets for Identical Assets
(Level 1)
 
 
Fair Value Based on Significant Other Observable Inputs
(Level 2)
 
 
Fair Value Based
on Significant
Unobservable Inputs
(Level 3)
 
 
Total
 
($ in millions)
 
2012
 
 
2011
 
 
2012
 
 
2011
 
 
2012
 
 
2011
 
 
2012
 
 
2011
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cash and cash equivalents:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cash
 
$
410.6
 
 
$
491.7
 
 
$
 
 
$
 
 
$
 
 
$
 
 
$
410.6
 
 
$
491.7
 
Money market funds
 
 
420.5
 
 
 
133.4
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
420.5
 
 
 
133.4
 
Certificate of deposit
 
 
0.2
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0.2
 
 
 
 
Commercial paper
 
 
 
 
 
 
 
 
91.0
 
 
 
140.4
 
 
 
 
 
 
 
 
 
91.0
 
 
 
140.4
 
U.S.non-governmental agency asset-backed securities
 
 
 
 
 
 
 
 
27.7
 
 
 
27.8
 
 
 
 
 
 
 
 
 
27.7
 
 
 
27.8
 
U.S. corporate obligations
 
 
5.6
 
 
 
29.1
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
5.6
 
 
 
29.1
 
U.S. Treasury securities
 
 
1.4
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1.4
 
 
 
 
Non-U.S. bank and other obligations
 
 
33.7
 
 
 
76.5
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
33.7
 
 
 
76.5
 
Short-term investments:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Commercial paper
 
 
 
 
 
 
 
 
211.0
 
 
 
213.5
 
 
 
 
 
 
 
 
 
211.0
 
 
 
213.5
 
U.S. Treasury securities
 
 
 
 
 
10.1
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
10.1
 
U.S. non-governmental agency asset-backed securities
 
 
 
 
 
 
 
 
68.7
 
 
 
77.3
 
 
 
 
 
 
 
 
 
68.7
 
 
 
77.3
 
U.S. corporate obligations
 
 
84.4
 
 
 
122.6
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
84.4
 
 
 
122.6
 
Derivatives, net asset (liability):
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Foreign currency contracts
 
 
 
 
 
 
 
 
(0.1
)
 
 
(13.8
)
 
 
 
 
 
 
 
 
(0.1
)
 
 
(13.8
)
Interest rate contracts
 
 
 
 
 
 
 
 
 
 
 
1.4
 
 
 
 
 
 
 
 
 
 
 
 
1.4
 
 
$
956.4
 
 
$
863.4
 
 
$
398.3
 
 
$
446.6
 
 
$
 
 
$
 
 
$
1,354.7
 
 
$
1,310.0
 
Information Relating to the Contracts and Estimated Fair Values Recorded in the Company's Consolidated Balance Sheets
Total gross volume bought (sold) by notional currency and maturity date on open derivative contracts at September 30, 2012 was as follows (in millions):

 
Notional Amount - Buy
 
 
Notional Amount - Sell
 
 
2012
 
 
2013
 
 
2014
 
 
Total
 
 
2012
 
 
2013
 
 
2014
 
 
2015
 
 
Total
 
FX Forward Contracts
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Notional currency in:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
EUR
 
 
83.7
 
 
 
65.3
 
 
 
17.8
 
 
 
166.8
 
 
 
(25.0
)
 
 
(7.8
)
 
 
 
 
 
 
 
 
(32.8
)
GBP
 
 
34.0
 
 
 
1.1
 
 
 
0.1
 
 
 
35.2
 
 
 
(33.1
)
 
 
(7.2
)
 
 
(0.3
)
 
 
 
 
 
(40.6
)
NOK
 
 
458.4
 
 
 
1,016.6
 
 
 
156.2
 
 
 
1,631.2
 
 
 
(140.7
)
 
 
(394.5
)
 
 
(0.4
)
 
 
 
 
 
(535.6
)
SGD
 
 
 
 
 
10.0
 
 
 
 
 
 
10.0
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
USD
 
 
17.8
 
 
 
27.3
 
 
 
0.2
 
 
 
45.3
 
 
 
(41.8
)
 
 
(113.6
)
 
 
(0.5
)
 
 
(0.5
)
 
 
(156.4
)
Schedule of Derivative Instruments in Statement of Financial Position, Fair Value
The fair values of derivative financial instruments recorded in the Company's Consolidated Condensed Balance Sheets at September 30, 2012 and December 31, 2011 were as follows (in millions):

 
September 30, 2012
 
 
December 31, 2011
 
 
Assets
 
 
Liabilities
 
 
Assets
 
 
Liabilities
 
 
 
 
 
 
 
 
 
 
 
 
 
Derivatives designated as hedges:
 
 
 
 
 
 
 
 
 
 
 
 
Foreign exchange contracts –
 
 
 
 
 
 
 
 
 
 
 
 
Current
 
$
9.7
 
 
$
6.4
 
 
$
1.9
 
 
$
7.0
 
Non-current
 
 
0.9
 
 
 
2.1
 
 
 
 
 
 
0.6
 
Total derivatives designated as hedges
 
 
10.6
 
 
 
8.5
 
 
 
1.9
 
 
 
7.6
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Derivatives not designated as hedges:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Foreign exchange contracts –
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Current
 
 
1.6
 
 
 
3.8
 
 
 
2.5
 
 
 
10.6
 
Non-current
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Interest Rate Swaps –
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Current
 
 
 
 
 
 
 
 
1.4
 
 
 
 
Non-current
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Total derivatives not designated as hedges
 
 
1.6
 
 
 
3.8
 
 
 
3.9
 
 
 
10.6
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Total derivatives
 
$
12.2
 
 
$
12.3
 
 
$
5.8
 
 
$
18.2
 
Schedule of Derivative Instruments in Cash Flow Hedges, Gain (Loss) in Statement of Financial Performance
The effects of derivative financial instruments designated as cash flow hedges on the Company's consolidated condensed financial statements for the three months ended September 30, 2012 and 2011 were as follows (in millions):

 
Effective Portion
 
Ineffective Portion and Other
 
Derivatives in Cash Flow Hedging Relationships
 
Amount of
Pre-Tax
Gain (Loss) Recognized in OCI on Derivatives at September 30,
 
Location of
Gain (Loss) Reclassified from Accumulated OCI into Income
 
Amount of
Gain (Loss) Reclassified from Accumulated OCI into Income at
September 30,
 
Location of
Gain (Loss) Recognized in Income on Derivatives
 
Amount of
Gain (Loss) Recognized in Income on Derivatives at
September 30,
 
 
2012
 
 
2011
 
 
2012
 
 
2011
 
 
2012
 
 
2011
 
 
 
Foreign exchange contracts
 
$
4.6
 
 
$
(7.1
)
Revenues
 
$
(3.5
)
 
$
0.6
 
Cost of goods sold-ineffectiveportion
 
$
 
 
$
(0.3
)
 
 
 
 
 
 
 
 
Cost of goods sold
 
 
 
 
 
(1.7
)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Depreciation expense
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Total
 
$
4.6
 
 
$
(7.1
)
 
$
(3.5
)
 
$
(1.1
)
 
$
 
 
$
(0.3
)

The effects of derivative financial instruments designated as cash flow hedges on the Company's consolidated condensed financial statements for the nine months ended September 30, 2012 and 2011 were as follows (in millions):

 
Effective Portion
 
Ineffective Portion and Other
 
Derivatives in Cash Flow Hedging Relationships
 
Amount of
Pre-Tax
Gain (Loss) Recognized in OCI on Derivatives at September 30,
 
Location of
Gain (Loss) Reclassified from Accumulated OCI into Income
 
Amount of
Gain (Loss) Reclassified from Accumulated OCI into Income at
September 30,
 
Location of
Gain (Loss) Recognized in Income on Derivatives
 
Amount of
Gain (Loss) Recognized in Income on Derivatives at
September 30,
 
 
2012
 
 
2011
 
 
2012
 
 
2011
 
 
2012
 
 
2011
 
 
 
Foreign exchange contracts
 
$
0.2
 
 
$
(4.2
)
Revenues
 
$
(5.5
)
 
$
2.5
 
Cost of goods sold-ineffectiveportion
 
$
(0.5
)
 
$
(0.7
)
 
 
 
 
 
 
 
 
Cost of goods sold
 
 
(4.8
)
 
 
(8.2
)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Depreciation expense
 
 
(0.1
)
 
 
(0.1
) 
 
 
 
 
 
 
 
 
Total
 
$
0.2
 
 
$
(4.2
)
 
$
(10.4
)
 
$
(5.8
)
 
$
(0.5
)
 
$
(0.7
)
Amount of Gain (Loss) Recognized on Derivatives not Designated as Hedging Instruments
The amount of pre-tax gain (loss) from the ineffective portion of derivatives not designated as hedging instruments was (in millions):

 
Three Months Ended
September 30,
 
 
Nine Months Ended
September 30,
 
 
2012
 
 
2011
 
 
2012
 
 
2011
 
 
 
 
 
 
 
 
 
 
 
 
 
Foreign currency contracts:
 
 
 
 
 
 
 
 
 
 
 
 
Cost of sales
 
$
 
 
$
(1.4
)
 
$
0.5
 
 
$
(2.2
)
Other costs
 
 
7.6
 
 
 
(6.4
)
 
 
13.2
 
 
 
(6.4
)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Interest rate swaps:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Interest, net
 
 
 
 
 
 
 
 
 
 
 
(0.2
)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Equity call options:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Other costs
 
 
 
 
 
(13.8
)
 
 
 
 
 
(12.2
)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Total
 
$
7.6
 
 
$
(21.6
)
 
$
13.7
 
 
$
(21.0
)